Similarly, neither did stromal expression of CD200R significantly predict DFS (p = 0.33) after surgery (Figure 3B) nor OS (p = 0.42) (Figure 3D) in early-stage NSCLC patients. The gene discussed is CD200R1; the disease is non-small cell lung carcinoma.